Combined hepatocellular carcinoma and cholangiocarcinoma
MONDO:0044791A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed. This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver. The prognosis of this tumor is poor.
Also known as: carcinoma of liver and intrahepatic biliary tract, liver and intrahepatic biliary tract carcinoma, Cholangiohepatoma, Hepatocholangiocarcinoma, Mixed hepatocellular cholangiocarcinoma, carcinoma of the liver and intrahepatic biliary tract, combined hepatocellular cancer and cholangiocarcinoma (bile duct cancer), combined hepatocellular cancer and intrahepatic bile duct cancer (cholangiocarcinoma)
2972 clinical trials for this condition and its sub-types, 8 tagged with Combined hepatocellular carcinoma and cholangiocarcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New radiation method aims to safely blast liver tumors
Disease control Recruiting nowThis early-phase trial tests a special radiation technique called vGRID SBRT for people with liver cancer that cannot be surgically removed. The main goal is to find the highest safe dose and check for side effects. Up to 18 adults with advanced or metastatic liver cancer will re…
Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can blood tests reveal how liver and bile duct cancers respond to treatment?
Knowledge-focused Recruiting nowThis study follows 150 adults with liver or bile duct cancer who are receiving standard treatments like surgery, ablation, or chemotherapy. Researchers will collect repeated blood samples before, during, and after treatment to analyze tumor DNA, immune cells, and proteins. The go…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC